← Latest papers
🧬 biology

Phylogenetic and Genomic Analysis of Multi-resistance in Salmonella Enterica

This study analyzes 20 African *Salmonella enterica* genomes to reveal that multidrug resistance is driven by a complex interplay of regional phylogenetic history, horizontal gene transfer, and the co-selection of antibiotic resistance by environmental biocides and heavy metals, necessitating a unified One Health approach for mitigation.

Original authors: Stuart Ngereza, Jemimah Ogwerel, Taye Motunrayo Ilesanmi, Sefi Omole Ijeboi, Godspower Oluwatomilade Akinmade

Published 2026-09-16
📖 6 min read🧠 Deep dive

Original authors: Stuart Ngereza, Jemimah Ogwerel, Taye Motunrayo Ilesanmi, Sefi Omole Ijeboi, Godspower Oluwatomilade Akinmade

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine a world where the tiny bacteria that cause food poisoning are not just learning to ignore the medicines we use to kill them, but are also becoming tougher because of the very things we use to keep our homes and hospitals clean. This is the story of Salmonella enterica, a common germ that makes people sick with fever and stomach trouble, and how it is evolving in Africa. Scientists have long known that when we use antibiotics too much, bacteria can change to survive them. But there is a newer, more complex idea: that bacteria can also survive because they are exposed to other chemicals, like the heavy metals found in mining runoff or the disinfectants in our soaps. These non-medical chemicals can accidentally teach the bacteria how to resist actual medicines. This happens because the same biological tools the bacteria use to push out a toxic metal can also push out an antibiotic. Understanding this hidden connection is crucial, because if we only stop using antibiotics but ignore these other chemicals, the bacteria might still become super-resistant.

A team of researchers from the Genomac Institute set out to map out exactly how this is happening across the African continent. They gathered genetic blueprints, known as genomes, from twenty different samples of Salmonella. These samples came from a wide variety of places, including human blood and stool, farm animals like chickens and cattle, and food products like sesame seeds and raw chicken. The samples were collected from eleven different countries, ranging from Tanzania and Nigeria to South Africa and the Democratic Republic of the Congo, covering a period from 2019 to 2025. By looking at the DNA of these germs, the researchers could see not just what medicines the bacteria could resist, but also how they were related to one another and what environmental pressures might have shaped them.

The first thing the scientists discovered was that these bacteria are constantly moving across borders. Even though the samples came from different countries, the genetic analysis showed that many of the bacteria were closely related, forming family groups that spanned national boundaries. For instance, bacteria found in Nigeria were genetically very similar to those found in Tunisia, and strains from Kenya matched closely with those from Malawi. This suggests that the bacteria are traveling along trade routes and through the movement of livestock and food, rather than staying stuck in one country. However, the researchers also found that the bacteria's ability to resist drugs was not tied to their family tree. Two bacteria could be very closely related genetically but have completely different resistance profiles. This means that the genes for resisting drugs are jumping between bacteria very quickly, likely carried on mobile pieces of DNA that can be shared easily, rather than being passed down slowly from parent to child.

One of the most surprising findings concerned how these bacteria resist a specific class of drugs called fluoroquinolones, which includes ciprofloxacin, a common treatment for severe infections. Usually, scientists expect a specific pump in the bacteria's cell wall to be the main reason for this resistance. But in these African samples, a different pump, called AcrEF-TolC, was the dominant driver of resistance, taking the place of the more common one. This is significant because ciprofloxacin is a critical medicine for treating invasive salmonella infections, and if the bacteria are using a different mechanism to resist it, doctors need to understand that to treat patients effectively. The study also found that the bacteria were not just resisting antibiotics; they were also resisting the chemicals we use to clean. The researchers found strong links between genes that help bacteria survive exposure to disinfectants like triclosan (found in soaps) and quaternary ammonium compounds (found in many cleaners) and the genes that make them resistant to antibiotics. This confirms that using these cleaning products can accidentally select for bacteria that are harder to kill with medicine.

The investigation also looked at heavy metals, which are often present in the environment due to mining and industrial activity. The study found that genes allowing bacteria to survive exposure to metals like gold, zinc, and silver were often found right next to genes that confer resistance to powerful antibiotics. In several of the countries where the samples came from, gold mining is a major industry, and zinc is commonly added to animal feed to help the animals grow. The researchers concluded that the pollution from these activities creates a constant, low-level pressure on the bacteria. This pressure forces the bacteria to keep their defense systems active, and in doing so, they also keep their resistance to antibiotics active. It is a case of cross-resistance, where surviving one threat automatically makes the bacteria stronger against another.

The researchers also looked at how the bacteria control these defense systems. They found that the bacteria use a sophisticated network of internal switches to turn their resistance pumps on and off. Interestingly, the bacteria in this study did not rely on one specific switch that is common in other parts of the world. Instead, they used a different set of regulators, suggesting that these African strains have evolved unique ways to manage their defenses based on their local environment. The study showed that the bacteria's core DNA, which defines what kind of germ it is, remained very stable and similar across the continent. But the extra DNA, which carries the resistance genes, was highly variable and constantly changing. This means that while the bacteria are related, their ability to cause treatment-resistant infections is being reshaped rapidly by local conditions.

Ultimately, this research paints a picture of a complex battle where the bacteria are winning not just because of how we use medicine, but because of how we manage our environment. The study suggests that fighting drug-resistant salmonella in Africa requires a broader approach. It is not enough to just control the use of antibiotics in hospitals and farms. The findings indicate that regulating the discharge of heavy metals from mines and controlling the use of certain biocides in cleaning products are equally important. If these environmental pressures are not addressed, the bacteria will continue to evolve and share resistance genes, making it harder to treat infections. The researchers recommend that countries in the region work together to monitor these bacteria across borders, regulate industrial pollution, and manage the use of non-antibiotic chemicals to break the cycle that is driving this resistance. By understanding the full picture of how these bacteria survive, from their family history to the chemicals they encounter every day, we can develop better strategies to protect public health.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →